Regarding 'Opportunity lost: Adjuvant chemotherapy in patients with Stage III colon cancer remains underused'
Surgery
.
2015 Dec;158(6):1745-6.
doi: 10.1016/j.surg.2015.06.030.
Epub 2015 Jul 21.
Authors
Katherine Mallin
1
,
Ashley M Loomis
2
,
Bryan Palis
2
,
Lawrence N Shulman
2
,
David P Winchester
2
Affiliations
1
American College of Surgeons. Electronic address: kmallin@facs.org.
2
American College of Surgeons.
PMID:
26209571
DOI:
10.1016/j.surg.2015.06.030
No abstract available
Publication types
Letter
Comment
MeSH terms
Adenocarcinoma / drug therapy*
Antineoplastic Agents / therapeutic use*
Colectomy*
Colonic Neoplasms / drug therapy*
Female
Guideline Adherence / statistics & numerical data*
Humans
Male
Substances
Antineoplastic Agents